triflusal has been researched along with Thromboembolism in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espasandín-Arias, M; García-Rodiño, S; Rodríguez-Granados, MT; Vázquez-Osorio, I | 1 |
| Aramendi, JI; Campos, V; Martinez-León, J; Mestres, CA; Muñoz, G; Navas, C | 1 |
| Murdoch, D; Plosker, GL | 1 |
| Borja, J; García, O; Izquierdo, I | 1 |
| Azanza, JR; Honorato, J | 1 |
| Berdié, J; Galindo, G; Morató, J; Navarro, MA; Peiró, R; Plana, A | 1 |
1 review(s) available for triflusal and Thromboembolism
| Article | Year |
|---|---|
Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Cerebral Infarction; Drug Interactions; Humans; Meta-Analysis as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Salicylates; Thromboembolism | 2006 |
1 trial(s) available for triflusal and Thromboembolism
| Article | Year |
|---|---|
Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
Topics: Acenocoumarol; Aged; Anticoagulants; Bioprosthesis; Epidemiologic Methods; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Salicylates; Thromboembolism | 2005 |
4 other study(ies) available for triflusal and Thromboembolism
| Article | Year |
|---|---|
Photosensitivity associated with systemic triflusal therapy.
Topics: Aged; Humans; Male; Photosensitivity Disorders; Salicylates; Thromboembolism; Urticaria | 2016 |
Antithrombotic treatment in atrial fibrillation. Response to: Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC: the risks of warfarin use in the elderly. Expert Opin. Drug Saf. (2006) 5(3):417-431.
Topics: Acenocoumarol; Aged; Anticoagulants; Atrial Fibrillation; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Salicylates; Thromboembolism; Treatment Outcome; Warfarin | 2006 |
[Triflusal].
Topics: Humans; Platelet Aggregation; Salicylates; Thromboembolism; Vascular Diseases | 1982 |
[Prevention of thromboembolic disease in patients with heart disease].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cross-Sectional Studies; Dipyridamole; Female; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Salicylates; Sex Factors; Thromboembolism; Ticlopidine | 2000 |